2015 Competitive Worldwide Market Acute Coronary Syndrome

Hexa Reports

Market Research Reports and Insightful Company Profiles

Acute Coronary Syndrome Market Size, Share,

Regional Outlook, Competitive Strategies and

Forecasts, Pipeline Review, H1 2015

Global Markets Direct's, 'Acute Coronary Syndrome - Pipeline Review, H1 2015', provides an overview of

the Acute Coronary Syndrome's therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Acute Coronary

Syndrome, complete with comparative analysis at various stages, therapeutics assessment by drug

target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest

updates, and featured news and press releases. It also reviews key players involved in the therapeutic

development for Acute Coronary Syndrome and special features on late-stage and discontinued

projects.

Browse Detail Report With TOC @ http://www.hexareports.com/report/acute-coronary-syndromepipeline-review-h1-2015/details

Scope

- The report provides a snapshot of the global therapeutic landscape of Acute Coronary Syndrome

- The report reviews key pipeline products under drug profile section which includes, product

description, MoA and R&D brief, licensing and collaboration details & other developmental activities

- The report reviews key players involved in the therapeutics development for Acute Coronary Syndrome

and enlists all their major and minor projects

- The report summarizes all the dormant and discontinued pipeline projects

Hexa Reports

Market Research Reports and Insightful Company Profiles

- A review of the Acute Coronary Syndrome products under development by companies and

universities/research institutes based on information derived from company and industry-specific

sources

- Pipeline products coverage based on various stages of development ranging from pre-registration till

discovery and undisclosed stages

- A detailed assessment of monotherapy and combination therapy pipeline...